Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population

Clinical Biochemistry

Volumn 49, Issue 9, 2016, Pages 657-662

  Rubin, Jonathan ^a,c   Matsushita, Kunihiro ^b   Lazo, Mariana ^b   Ballantyne, Christie M ^d   Nambi, Vijay ^d,e   Hoogeveen, Ron ^d   Sharrett, A Richey ^b   Blumenthal, Roger S ^f   Coresh, Josef ^b   Selvin, Elizabeth ^b  

^a NewYork Presbyterian Hospital   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Epidemiology; Risk factors; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; HIGH SENSITIVITY CARDIAC TROPONIN T; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN T; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLACK PERSON; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRINKING BEHAVIOR; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD; FOLLOW UP; HEART DISEASES; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ADULT; BIOMARKERS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TROPONIN T; UNITED STATES;

EID: 84962019999     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.01.024     Document Type: Article

References (24)

1. Newby L.K., Jesse R.L., Babb J.D., et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on clinical expert consensus documents. J. Am. Coll. Cardiol. 2012, 60:2427-2463.
2. Wallace T.W., Abdullah S.M., Drazner M.H., et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006, 113:1958-1965.
3. Saunders J.T., Nambi V., de Lemos J.A., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123:1367-1376.
4. de Lemos J.A., Drazner M.H., Omland T., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010, 304:2503-2512.
5. deFilippi C.R., de Lemos J.A., Christenson R.H., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
6. Gore M.O., Seliger S.L., Defilippi C.R., et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J. Am. Coll. Cardiol. 2014, 63:1441-1448.
7. McEvoy J.W., Lazo M., Chen Y., et al. Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: the Atherosclerosis Risk in Communities Cohort Study. Int. J. Cardiol. 2015, 187:651-657.
8. McEvoy J.W., Chen Y., Nambi V., et al. High-sensitivity cardiac troponin T and risk of hypertension. Circulation 2015, 132:825-833.
9. Martinez-Rumayor A.A., de Lemos J.A., Rohatgi A.K., et al. Addition of highly sensitive troponin T and N-terminal pro-B-type natriuretic peptide to electrocardiography for detection of left ventricular hypertrophy: results from the Dallas Heart Study. Hypertension 2013, 61:105-111.
10. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am. J. Epidemiol. 1989, 129:687-702.
11. White A.D., Folsom A.R., Chambless L.E., et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J. Clin. Epidemiol. 1996, 49:223-233.
12. Operations manual no. 2: Cohort Component Procedures, version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina 1987.
13. Operations manual no. 11: Sitting Blood Pressure, Version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina 1987.
14. National Heart, Lung, and Blood Institute Atherosclerosis Risk in Communities Study: manual 8: lipid and lipoprotein determinations. Version 2.0 ed. Chapel Hill, NC: ARIC Coordinating Center 1994.
15. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150:604-612.
16. Operations manual no. 10: Clinical Chemistry Determinations, version 1.0. Chapel Hill: ARIC Coordinating Center, School of Public Health, University of North Carolina 1987.
17. Chambless L.E., Folsom A.R., Sharrett A.R., et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J. Clin. Epidemiol. 2003, 56:880-890.
18. Agarwal S.K., Avery C.L., Ballantyne C.M., et al. Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study. Clin. Chem. 2011, 57:891-897.
19. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 2010, 56:254-261.
20. Lloyd-Jones D.M., Hong Y., Labarthe D., et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond. Circulation 2010, 121:586-613.
21. Daniels L.B., Laughlin G.A., Clopton P., Maisel A.S., Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J. Am. Coll. Cardiol. 2008, 52:450-459.
22. McQueen M.J., Kavsak P.A., Xu L., Shestakovska O., Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin. Biochem. 2013, 46:5-9.
23. White H.D. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?. J. Am. Coll. Cardiol. 2011, 57:2406-2408.
24. Hickman P.E., Potter J.M., Aroney C., et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin. Chim. Acta 2010, 411:318-323.